These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26159444)

  • 1. Advances in pharmacotherapy to treat kidney transplant rejection.
    Bamoulid J; Staeck O; Halleck F; Dürr M; Paliege A; Lachmann N; Brakemeier S; Liefeldt L; Budde K
    Expert Opin Pharmacother; 2015; 16(11):1627-48. PubMed ID: 26159444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current pharmacotherapeutical options for the prevention of kidney transplant rejection.
    Schaefer SM; Süsal C; Sommerer C; Zeier M; Morath C
    Expert Opin Pharmacother; 2013 Jun; 14(8):1029-41. PubMed ID: 23560807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for minimization strategies: current problems of immunosuppression.
    Bamoulid J; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K
    Transpl Int; 2015 Aug; 28(8):891-900. PubMed ID: 25752992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and Future.
    Galián JA; Mrowiec A; Muro M
    Expert Opin Ther Targets; 2016 Jul; 20(7):859-67. PubMed ID: 26695424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
    Lunsford KE; Barbas AS; Brennan TV
    Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.
    van den Hoogen MW; Hoitsma AJ; Hilbrands LB
    Expert Opin Biol Ther; 2012 Aug; 12(8):1031-42. PubMed ID: 22583145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.
    Wong TC; Lo CM; Fung JY
    Expert Opin Emerg Drugs; 2017 Jun; 22(2):123-136. PubMed ID: 28503959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best?
    Zhou Y; Li X; Liu Y; Sun Q
    Immunotherapy; 2017 Jan; 9(1):47-55. PubMed ID: 28000532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacologic therapy in renal transplantation.
    Shoker AS
    Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte markers and prediction of long-term renal allograft acceptance.
    Babel N; Reinke P; Volk HD
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):489-94. PubMed ID: 19724222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical renal transplantation: where are we now, what are our key challenges?
    Chapman JR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S3-6. PubMed ID: 21095448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive strategies to improve outcomes of kidney transplantation.
    Tang IY; Meier-Kriesche HU; Kaplan B
    Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant immunology for non-immunologist.
    Heeger PS; Dinavahi R
    Mt Sinai J Med; 2012; 79(3):376-87. PubMed ID: 22678861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation.
    Vianna R
    Minerva Pediatr; 2009 Jun; 61(3):293-303. PubMed ID: 19461573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction.
    Zhang PL; Malek SK; Blasick TM; Pennington JR; Masker KK; Lun M; Potdar S
    Ann Clin Lab Sci; 2007; 37(2):121-6. PubMed ID: 17522366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of antibodies improves outcome of renal transplantation.
    Trivedi HL; Vanikar AV; Gumber MR; Patel HV; Shah PR; Kute VB
    Transplant Proc; 2012 Jan; 44(1):241-7. PubMed ID: 22310623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome.
    Coll E; Crespo M; Solé M; Campistol JM; Cofàn F; Esforzado N; Ricart MJ; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2004 Mar; 36(2 Suppl):114S-116S. PubMed ID: 15041318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrology--Part 2. Strategies in the immunosuppression after kidney transplantation].
    Sperschneider H; Heemann U; Stein G
    Med Klin (Munich); 2003 Mar; 98(3):140-5. PubMed ID: 12647088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.